| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.33 | 0.02 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |